A single injection of denosumab (Prolia, Amgen), frequently used to treat osteoporosis, may reduce the need for revision surgery in patients with symptomatic osteolysis following total hip ...

DALLAS — Retention of a well-fixed stem and modular exchange to a ceramic head led to resolution of symptoms and decreased metal ion levels among patients with a metal-on-polyethylene bearing who ...

Needing a hip replacement is unfortunate, but even more unfortunate is to need to do it again. Surgeons at Osaka Metropolitan University have provided new insights into the performance of two types of ...

A comprehensive study using nationwide data on hip and knee replacements in England has found that one in 75 patients require a revision of their joint replacement after three years. Although this ...

Please provide your email address to receive an email when new articles are posted on . Projections on future joint arthroplasty demands have not been accurate in the past because many factors may be ...

Researchers have found the osteoporosis drug, denosumab, could protect patients from osteolysis, reduce the need for re-operations, and reduce the health burden of this disease. More than half of ...

Objectives Total hip replacement (THR) is one of the most common elective orthopaedic surgeries performed, with increasing demand among younger individuals. Few evidence-based guidelines exist on safe ...